Insulin resistance in the brain: An old-age or new-age problem?

Biochemical Pharmacology

Volumn 84, Issue 6, 2012, Pages 737-745

  Williamson, Ritchie ^a   McNeilly, Alison ^a   Sutherland, Calum ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Dementia; Diabetes; Insulin resistance

Indexed keywords

INSULIN; INSULIN RECEPTOR; METFORMIN; SOMATOMEDIN C;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN DISEASE; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GENE DELETION; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFE EXPECTANCY; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 84864921644     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.05.007     Document Type: Note

References (100)

1. C. MacKnight, K. Rockwood, E. Awalt, and I. McDowell Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging Dement Geriatr Cogn Disord 14 2002 77 83
2. A. Cole, A. Astell, C. Green, and C. Sutherland Molecular connections between dementia and diabetes Neurosci Biobehav Rev 31 2007 1046 1063
3. T. Cukierman, H.C. Gerstein, and J.D. Williamson Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies Diabetologia 48 2005 2460 2469
4. K. Yaffe, T. Blackwell, A.M. Kanaya, N. Davidowitz, E. Barrett-Connor, and K. Kruegeer Diabetes, impaired fasting glucose, and development of cognitive impairment in older women Neurology 63 2004 656 663
5. M.F. Elias, P.K. Elias, L.M. Sullivan, P.A. Wolf, and R.B. D'Agostino Lower cognitive function in the presence of obesity and hypertension: the Framlingham heart study Int J Obes Relat Metab Disord 27 2003 260 268
6. R.A. Whitmer, E.P. Gunderson, E. Barrett-Connor, C.P.J. Quesenberry, and K. Yaffe Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study BMJ 330 2005 1360
7. T. Ohara, Y. Doi, T. Ninomiya, Y. Hirakawa, J. Hata, and T. Iwaki Glucose tolerance status and risk of dementia in the community: the Hisayama Study Neurology 77 2011 1126 1134
8. R. Cosway, M.W. Strachan, A. Dougall, B.M. Frier, and I.J. Deary Cognitive function and information processing in type 2 diabetes Diabet Med 18 2001 803 810
9. G.I. Shulman Cellular mechanisms of insulin resistance J Clin Invest 106 2000 171 176
10. J.B.C. Carvalheira, E.B. Ribeiro, E.P. Araujo, R.B. Guimaraes, M.M. Telles, and M. Torsoni Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats Diabetologia 46 2003 1629 1640
11. J.R. Petrie, S. Ueda, D.J. Webb, H.L. Elliott, and J.M.C. Connell Insulin sensitivity and endothelial function: a physiological relationship with implications for pathophysiology of cardiovascular disease Circulation 93 1996 1331 1333
12. M. Rajkhowa, S. Brett, D.J. Cuthbertson, C. Lipina, A.J. Ruiz-Alcaraz, and G.E. Thomas Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo Biochem J 418 2009 665 671
13. M.F. White IRS proteins and the common path to diabetes Am J Physiol Endocrinol Metab 283 2002 E413 E422
14. K. Morino, K.F. Petersen, S. Dufour, D. Befroy, J. Frattini, and N. Shatzkes Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents J Clin Invest 115 2005 3587 3593
15. D.J. Withers, and White M. Perspective The insulin signaling system - a common link in the pathogenesis of type 2 diabetes Endocrinology 141 2000 1917 1921
16. A. Mora, D. Komander, D.M. van Aalten, and D.R. Alessi PDK1, the master regulator of AGC kinase signal transduction Semin Cell Dev Biol 15 2004 161 170
17. D.A.E. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings Inhibition of GSK3 by insulin mediated by protein kinase B Nature 378 1995 785 789
18. G. Rena, S. Guo, S.C. Cichy, T.G. Unterman, and P. Cohen Phosphorylation of the transcription factor forkhead family member FKHR by PKB J Biol Chem 274 1999 17179 17183
19. P.A. Lochhead, M.P. Coghlan, S.Q.J. Rice, and C. Sutherland Inhibition of GSK3 selectively reduces G6Pase and PEPCK gene expression Diabetes 50 2001 937 947
20. M. Bouskila, M.F. Hirshman, J. Jensen, L.J. Goodyear, and K. Sakamoto Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle Am J Physiol Endocrinol Metab 294 2008 E28 E35
21. H. Sano, S. Kane, E. Sano, C.P. Miinea, J.M. Asara, and W.S. Lane Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation J Biol Chem 278 2003 14599 14602
22. E. Vander Haar, S.I. Lee, S. Bandhakavi, T.J. Griffin, and D.H. Kim Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 Nat Cell Biol 9 2007 316 323
23. W.A. Banks, J.B. Jaspan, W. Huang, and A.J. Kastin Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin Peptides 18 1997 1423 1429
24. W.A. Banks, J.B. Jaspan, and A.J. Kastin Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin Peptides 18 1997 1577 1584
25. S. Craft Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications Alzheimer Dis Assoc Disord 20 2006 298 301
26. B.J. Wallum, G.J. Taborsky Jr., D. Porte Jr., D.P. Figlewicz, L. Jacobson, and J.C. Beard Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man J Clin Endocrinol Metab 64 1987 190 194
27. M. Schafer, and S.L. Erdo Development of glutamate neurotoxicity in cortical cultures: induction of vulnerability by insulin Brain Res Dev Brain Res 62 1991 293 296
28. W. Zhao, H. Chen, H. Xu, E. Moore, N. Meiri, and M.J. Quon Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats J Biol Chem 274 1999 34893 34902
29. J.W. Unger, J.N. Livingston, and A.M. Moss Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects Prog Neurobiol 36 1991 343 362
30. A. Apostolatos, S. Song, S. Acosta, M. Peart, J.E. Watson, and P. Bickford Insulin promotes neuronal survival via the alternatively spliced protein kinase CdeltaII isoform J Biol Chem 287 2012 9299 9310
31. M.A. Reger, G.S. Watson, W.H. Frey 2nd, L.D. Baker, B. Cholerton, and M.L. Keeling Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype Neurobiol Aging 27 2006 451 458
32. W. Kern, A. Peters, B. Fruehwald-Schultes, E. Deininger, J. Born, and H.L. Fehm Improving influence of insulin on cognitive functions in humans Neuroendocrinology 74 2001 270 280
33. S. Craft, S. Asthana, D.G. Cook, L.D. Baker, M. Cherrier, and K. Purganan Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype Psychoneuroendocrinology 28 2003 809 822
34. M. Vanhanen, K. Koivisto, J. Kuusisto, L. Mykkanen, E.L. Helkala, and T. Hanninen Cognitive function in an elderly population with persistent impaired glucose tolerance Diabetes Care 21 1998 398 402
35. A. Convit, O.T. Wolf, C. Tarshish, and M.J. de Leon Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly Proc Natl Acad Sci U S A 100 2003 2019 2022
36. L. Frolich, D. Blum-Degen, H.G. Bernstein, S. Engelsberger, J. Humrich, and S. Laufer Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease J Neural Transm 105 1998 423 438
37. S. Craft Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment Curr Alzheimer Res 4 2007 147 152
38. E.J. Rivera, A. Goldin, N. Fulmer, R. Tavares, J.R. Wands, and S.M. de la Monte Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine J Alzheimers Dis 8 2005 247 268
39. E. Steen, B.M. Terry, E.J. Rivera, J.L. Cannon, T.R. Neely, and R. Tavares Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes J Alzheimers Dis 7 2005 63 80
40. E.M. Bingham, D. Hopkins, D. Smith, A. Pernet, W. Hallett, and L. Reed The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study Diabetes 51 2002 3384 3390
41. A.M. Brant, T.J. Jess, G. Milligan, C.M. Brown, and G.W. Gould Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system Biochem Biophys Res Commun 192 1993 1297 1302
42. R. Suzuki, K. Lee, E. Jing, S.B. Biddinger, J.G. McDonald, and T.J. Montine Diabetes and insulin in regulation of brain cholesterol metabolism Cell Metab 12 2010 567 579
43. S.R. Kopf, and C.M. Baratti Effects of posttraining administration of insulin on retention of a habituation response in mice: participation of a central cholinergic mechanism Neurobiol Learn Mem 71 1999 50 61
44. D.P. Figlewicz, P. Szot, P.A. Israel, C. Payne, and D.M. Dorsa Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus Brain Res 602 1993 161 164
45. V.A. Skeberdis, J. Lan, X. Zheng, R.S. Zukin, and M.V. Bennett Insulin promotes rapid delivery of N-methyl-d-aspartate receptors to the cell surface by exocytosis Proc Natl Acad Sci U S A 98 2001 3561 3566
46. J.C. Bruning, D. Gautam, D.J. Burks, J. Gillette, M. Schubert, and P.C. Orban Role of brain insulin receptor in control of body weight and reproduction Science 289 2000 2122 2125
47. M. Schubert, D. Gautam, D. Surjo, K. Ueki, S. Baudler, and D. Schubert Role for neuronal insulin resistance in neurodegenerative diseases Proc Natl Acad Sci U S A 101 2004 3100 3105
48. S.J. Fisher, J.C. Bruning, S. Lannon, and C.R. Kahn Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia Diabetes 54 2005 1447 1451
49. K.A. Diggs-Andrews, X. Zhang, Z. Song, D. Daphna-Iken, V.H. Routh, and S.J. Fisher Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia Diabetes 59 2010 2271 2280
50. M. Sanchez-Alavez, O. Osborn, I.V. Tabarean, K.H. Holmberg, J. Eberwine, and C.R. Kahn Insulin-like growth factor 1-mediated hyperthermia involves anterior hypothalamic insulin receptors J Biol Chem 286 2011 14983 14990
51. T. Scherer, J. O'Hare, K. Diggs-Andrews, M. Schweiger, B. Cheng, and C. Lindtner Brain insulin controls adipose tissue lipolysis and lipogenesis Cell Metab 13 2011 183 194
52. L. Koch, F.T. Wunderlich, J. Seibler, A.C. Konner, B. Hampel, and S. Irlenbusch Central insulin action regulates peripheral glucose and fat metabolism in mice J Clin Invest 118 2008 2132 2147
53. S. Obici, Z. Feng, G. Karkanias, D.G. Baskin, and L. Rossetti Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats Nat Neurosci 5 2002 566 572
54. S.A. Paranjape, O. Chan, W. Zhu, A.M. Horblitt, C.A. Grillo, and S. Wilson Chronic reduction of insulin receptors in the ventromedial hypothalamus produces glucose intolerance and islet dysfunction in the absence of weight gain Am J Physiol Endocrinol Metab 301 2011 E978 E983
55. C.A. Grillo, K.L. Tamashiro, G.G. Piroli, S. Melhorn, J.T. Gass, and R.J. Newsom Lentivirus-mediated downregulation of hypothalamic insulin receptor expression Physiol Behav 92 2007 691 701
56. T. Klockener, S. Hess, B.F. Belgardt, L. Paeger, L.A. Verhagen, and A. Husch High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons Nat Neurosci 14 2011 911 918
57. A.C. Konner, R. Janoschek, L. Plum, S.D. Jordan, E. Rother, and X. Ma Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production Cell Metab 5 2007 438 449
58. A.C. Konner, S. Hess, S. Tovar, A. Mesaros, C. Sanchez-Lasheras, and N. Evers Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis Cell Metab 13 2011 720 728
59. L. Ho, W. Qin, P.N. Pompl, Z. Xiang, J.X. Wang, and Z. Zhao Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease FASEB J 18 2004 902 908
60. C. Julien, C. Tremblay, A. Phivilay, L. Berthiaume, V. Emond, and P. Julien High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model Neurobiol Aging 31 2010 1516 1531
61. S. Takeda, N. Sato, K. Uchio-Yamada, K. Sawada, T. Kunieda, and D. Takeuchi Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes Proc Natl Acad Sci U S A 107 2010 7036 7041
62. O. Stohr, K. Schilbach, L. Moll, M.M. Hettich, S. Freude, and F.T. Wunderlich Insulin receptor signaling mediates APP processing and beta-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease Age (Dordrecht) 2011 [Epub ahead of print]
63. S. Freude, M.M. Hettich, C. Schumann, O. Stohr, L. Koch, and C. Kohler Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease FASEB J 23 2009 3315 3324
64. A.D. McNeilly, R. Williamson, C. Sutherland, D.J. Balfour, and C.A. Stewart High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task Behav Brain Res 217 2011 134 141
65. A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease Endocr Rev 30 2009 586 623
66. A. Fafalios, J. Ma, X. Tan, J. Stoops, J. Luo, and M.C. Defrances A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism Nat Med 17 2011 1577 1584
67. A. Aleman, and I. Torres-Aleman Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan Prog Neurobiol 89 2009 256 265
68. J. Svensson, M. Diez, J. Engel, C. Wass, A. Tivesten, and J.O. Jansson Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice J Endocrinol 189 2006 617 627
69. Y. Liu, F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.X. Gong Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes J Pathol 225 2011 54 62
70. L. Logie, A.J. Ruiz-Alcaraz, M. Keane, Y.L. Woods, J. Bain, and R. Marquez Characterization of a protein kinase B inhibitor in vitro and in insulin-treated liver cells Diabetes 56 2007 2218 2227
71. M. Townsend, T. Mehta, and D.J. Selkoe Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway J Biol Chem 282 2007 33305 33312
72. F.G. De Felice, M.N. Vieira, T.R. Bomfim, H. Decker, P.T. Velasco, and M.P. Lambert Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers Proc Natl Acad Sci U S A 106 2009 1971 1976
73. B. Diaz, J. Serna, F. De Pablo, and E.J. de la Rosa In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesis Development 127 2000 1641 1649
74. X. Wu, C.E. Reiter, D.A. Antonetti, S.R. Kimball, L.S. Jefferson, and T.W. Gardner Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner J Biol Chem 279 2004 9167 9175
75. W.Q. Qiu, D.M. Walsh, Z. Ye, K. Vekrellis, J. Zhang, and M.B. Podlisny Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation J Biol Chem 273 1998 32730 32738
76. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, and M.P. Frosch Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci U S A 100 2003 4162 4167
77. D.P. Hanger, A. Seereeram, and W. Noble Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease Expert Rev Neurother 9 2009 1647 1666
78. M.P. Soutar, W.Y. Kim, R. Williamson, M. Peggie, C.J. Hastie, and H. McLauchlan Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain J Neurochem 115 2010 974 983
79. C.M. Ryan, M.I. Freed, J.A. Rood, A.R. Cobitz, B.R. Waterhouse, and M.W. Strachan Improving metabolic control leads to better working memory in adults with type 2 diabetes Diabetes Care 29 2006 345 351
80. A.M. Abbatecola, M.R. Rizzo, M. Barbieri, R. Grella, A. Arciello, and M.T. Laieta Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics Neurology 67 2006 235 240
81. M.W. Strachan, I.J. Deary, F.M. Ewing, and B.M. Frier Is type II diabetes associated with an increased risk of cognitive dysfunction. A critical review of published studies Diabetes Care 20 1997 438 445
82. A.J. Sommerfield, I.J. Deary, and B.M. Frier Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes Diabetes Care 27 2004 2335 2340
83. L.J. Launer, M.E. Miller, J.D. Williamson, R.M. Lazar, H.C. Gerstein, and A.M. Murray Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy Lancet Neurol 10 2011 969 977
84. H. Johnston, H. Boutin, and S.M. Allan Assessing the contribution of inflammation in models of Alzheimer's disease Biochem Soc Trans 39 2011 886 890
85. J. Rogers, D. Mastroeni, B. Leonard, J. Joyce, and A. Grover Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder Int Rev Neurobiol 82 2007 235 246
86. P.J. Pistell, C.D. Morrison, S. Gupta, A.G. Knight, J.N. Keller, and D.K. Ingram Cognitive impairment following high fat diet consumption is associated with brain inflammation J Neuroimmunol 219 2010 25 32
87. M.A. Fishel, G.S. Watson, T.J. Montine, Q. Wang, P.S. Green, and J.J. Kulstad Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults Arch Neurol 62 2005 1539 1544
88. S.A. Wrighten, G.G. Piroli, C.A. Grillo, and L.P. Reagan A look inside the diabetic brain: contributors to diabetes-induced brain aging Biochim Biophys Acta 1792 2009 444 453
89. U. Kintscher, and R.E. Law PPARgamma-mediated insulin sensitization: the importance of fat versus muscle Am J Physiol Endocrinol Metab 288 2005 E287 E291
90. C.K. Combs, D.E. Johnson, J.C. Karlo, S.B. Cannady, and G.E. Landreth Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists J Neurosci 20 2000 558 567
91. P. Delerive, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors in inflammation control J Endocrinol 169 2001 453 459
92. W.A. Pedersen, and E.R. Flynn Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease Neurobiol Dis 17 2004 500 506
93. G.S. Watson, B.A. Cholerton, M.A. Reger, L.D. Baker, S.R. Plymate, and S. Asthana Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study Am J Geriatr Psychiatry 13 2005 950 958
94. C. Harrington, S. Sawchak, C. Chiang, J. Davies, C. Donovan, and A.M. Saunders Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies Curr Alzheimer Res 8 2011 592 606
95. E. Kickstein, S. Krauss, P. Thornhill, D. Rutschow, R. Zeller, and J. Sharkey Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling Proc Natl Acad Sci U S A 107 2010 21830 21835
96. Y. Chen, K. Zhou, R. Wang, Y. Liu, Y.D. Kwak, and T. Ma Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription Proc Natl Acad Sci U S A 106 2009 3907 3912
97. C.C. Hsu, M.L. Wahlqvist, M.S. Lee, and H.N. Tsai Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin J Alzheimers Dis 24 2011 485 493
98. P.L. McClean, V. Parthsarathy, E. Faivre, and C. Holscher The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease J Neurosci 31 2011 6587 6594
99. T.R. Bomfim, L. Forny-Germano, L.B. Sathler, J. Brito-Moreira, J.C. Houzel, and H. Decker An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Abeta oligomers J Clin Invest 122 2012 1339 1353
100. H.B. Schioth, W.H. Frey, S.J. Brooks, and C. Benedict Insulin to treat Alzheimer's disease: just follow your nose Expert Rev Clin Pharmacol 5 2012 17 20